Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 73Unknown 47Terminated 16Recruiting 15Active not recruiting 11Not yet recruiting 10Withdrawn 7Suspended 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1

Conditions

Neoplasms 1Esophageal Neoplasms 1

Interventions

Specimen Handling 31Magnetic Resonance Spectroscopy 19Biopsy 16Cyclophosphamide 15Nivolumab 10Paclitaxel 9Vincristine 8Cisplatin 8venetoclax 7Prednisone 7Gemcitabine 7Doxorubicin 7Bevacizumab 7Azacitidine 7pembrolizumab 6Radiotherapy 6Fluorouracil 6Etoposide 6Drug Therapy 6Docetaxel 6Surgical Procedures, Operative 5Rituximab 5Radiosurgery 5Oxaliplatin 5Irinotecan 5Injections 5Everolimus 5Capecitabine 5fludarabine phosphate 4Taxes 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Radiofrequency Ablation × Clear all
NCT02146508 2023-12-11

EXPECT

Tenwek Hospital

Phase NA Suspended
75 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT00868647 2009-09-01

Radiofrequency Ablation (RFA) Of Tumors Acquired In Childhood

Seattle Children's Hospital

Phase 2 Suspended
60 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡